首页 | 本学科首页   官方微博 | 高级检索  
     

贵州省接受抗病毒治疗艾滋病患者的生存因素分析
引用本文:陈洋,申莉梅,李豫,李进岚,黄璐,安竹,李志坚,鲁俊端,张晓萍,刘跃辉,安邦权. 贵州省接受抗病毒治疗艾滋病患者的生存因素分析[J]. 中国感染控制杂志, 2017, 16(10): 925-930. DOI: 10.3969/j.issn.1671-9638.2017.10.007
作者姓名:陈洋  申莉梅  李豫  李进岚  黄璐  安竹  李志坚  鲁俊端  张晓萍  刘跃辉  安邦权
作者单位:贵州省接受抗病毒治疗艾滋病患者的生存因素分析
基金项目:

贵州省科技计划项目(黔科合SY[2013]3052号)

摘    要:目的了解贵州省人类免疫缺陷病毒(HIV)感染者和艾滋病(AIDS)患者接受抗逆转录病毒治疗后的生存时间及其影响因素。方法采用回顾性队列研究方法,分析贵州省2005—2016年接受抗病毒治疗的AIDS患者的生存时间,应用寿命表法计算生存概率,运用Cox比例风险回归模型分析其影响因素。结果共纳入分析15921例AIDS患者,开始治疗时的平均年龄为(42.13±14.40)岁,已婚/同居者占58.61%。治疗后患者的随访时间[中位数(P25~P75):15.96(6.00~33.00)]月。9.77%随访病例发生死亡,其中59.29%的死亡发生在开始治疗的12个月内;第1、5、10年的生存率分别为93.00%,82.00%和74.00%。Cox比例风险回归模型分析结果显示:女性患者死亡风险是男性的0.58倍(95%CI:0.49~0.68);随着年龄增高,患者死亡风险亦增高;基线CD4+T淋巴细胞计数越高,患者死亡风险越低;治疗前无疾病症状体征的患者死亡风险是有症状体征的0.70倍(95%CI:0.60~0.81)。结论贵州省AIDS患者抗病毒治疗情况整体较好,应高度关注死亡危险因素较高的患者,建议在扩增治疗患者的同时注重提高医疗水平和服务质量。

关 键 词:艾滋病  人类免疫缺陷病毒  艾滋病患者  抗病毒治疗  生存分析  
收稿时间:2016-09-10
修稿时间:2016-11-23

Survival factors of AIDS patients receiving antiretroviral therapy in Guizhou Province
CHEN Yang,SHEN Li mei,LI Yu,LI Jin lan,HUANG Lu,AN Zhu,LI Zhi jian,LU Jun duan,ZHANG Xiao ping,LIU Yue hui,AN Bang quan. Survival factors of AIDS patients receiving antiretroviral therapy in Guizhou Province[J]. Chinese Journal of Infection Control, 2017, 16(10): 925-930. DOI: 10.3969/j.issn.1671-9638.2017.10.007
Authors:CHEN Yang  SHEN Li mei  LI Yu  LI Jin lan  HUANG Lu  AN Zhu  LI Zhi jian  LU Jun duan  ZHANG Xiao ping  LIU Yue hui  AN Bang quan
Affiliation:1.Guizhou Center for Disease Control and Prevention, Guiyang 550004, China;2.Guizhou Provincial People’s Hospital, Guiyang 550005, China
Abstract:ObjectiveTo explore the survival time and its influencing factors of patients in Guizhou Province after they received antiretroviral therapy(ART) for treating human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). MethodsA retrospective cohort analysis was conducted to analyze survival time of AIDS patients who received ART in Guizhou Province in 2005 2016, life table method was used to calculate the survival probability, Cox proportional hazards regression model was used to analyze the influencing factors of survival time. ResultsA total of 15 921 patients were included in the study, the median age at the beginning of therapy was(42.13±14.40)years old, 58.61% of patients were married/housemate. The length of ART follow up was (median[P25-P75]: 15.96[ 6.00-33.00]) months. 9.77% of the follow up cases died, 59.29% of the deaths occurred within 12 months of initiation of treatment; survival rates in the first, fifth, and tenth year were 93.00%, 82.00%, and 74.00% respectively. Cox proportional hazards regression model analysis showed that female patients were 0.58 times more likely to die than male patients(95% CI:0.49-0.68);the risk of death increased with increase of ages; the higher the baseline CD4+T lymphocyte count, the lower the risk of death; the risk of death in patients without symptoms or signs before therapy was 0.70 times than those with symptoms or signs(95% CI:0.60-0.81). ConclusionThe antiviral therapy of AIDS patients in Guizhou Province is generally well, patients with high risk factors for death should be paid high attention, it is suggested that medical level and service quality should be improved when patients are treated.
Keywords:acquired immunodeficiency syndrome  human immunodeficiency virus  AIDS patient  antiretroviral therapy  survival analysis  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号